News Roundup: January 23 to January 27
Your weekly roundup of the latest news from Drug Topics®.
Breaking: FDA Committee Votes in Favor of New, Unified COVID-19 Vaccine Strategy
Recommendations from the unanimous vote must be adopted by the FDA and CDC.
Navigating and Treating 'New Year Depression' in Patients
There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.
Smart Injector Insulin Pen Device, Mallya, Cleared by FDA
Mallya can provide convenience for insulin pen users; however, it has yet to be released in the United States.
2a Trial of Psychedelic for Major Depressive Disorder Shows Positive Results
SPL026 with supportive therapy sees positive results in patients with major depressive disorder.
For the First Time Medicaid Net Drug Spending Hits Double-Digits
Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
